87
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Long Non-Coding RNA TMPO-AS1 Promotes Cervical Cancer Cell Proliferation, Migration, and Invasion by Regulating miR-143-3p/ZEB1 Axis

, &
Pages 1587-1599 | Published online: 03 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jianhua Qin, Tingting Zhu, Weihua Wu, Huan Chen & Yi He. (2021) Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis. OncoTargets and Therapy 14, pages 393-402.
Read now
Biao Xing, Xiao-Feng Qiao, Yan-Hua Qiu & Xin Li. (2021) TMPO-AS1 Regulates the Aggressiveness-Associated Traits of Nasopharyngeal Carcinoma Cells Through Sponging miR-320a. Cancer Management and Research 13, pages 415-425.
Read now

Articles from other publishers (13)

Shelesh Krishna Saraswat, Bashar Shaker Mahmood, Freddy Ajila, Doaa Saadi Kareem, Mariem Alwan, Zainab H. Athab, Jalal Brism Shaier & Seyed Reza Hosseinifard. (2024) Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers. Pathology - Research and Practice 255, pages 155190.
Crossref
Jianjun Zhao, Pengjie Chen, Chao Tan, Xiaolong Cheng, Weichuan Zhang, Chong Shen & Dongli Zhang. (2023) LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis. Aging 15:19, pages 10057-10071.
Crossref
Lee Armstrong, Colin E. Willoughby & Declan J. McKenna. (2023) Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer. Cells 12:18, pages 2207.
Crossref
Ahmed S. Doghish, Mohamed A. Ali, Salah S. Elyan, Mahmoud A. Elrebehy, Hend H. Mohamed, Reda M. Mansour, Ayatallah Elgohary, Aml Ghanem, Ahmed H.I. Faraag, Nourhan M. Abdelmaksoud & Hebatallah Ahmed Mohamed Moustafa. (2023) miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay. Pathology - Research and Practice 244, pages 154386.
Crossref
Xinyi Du, Xiaowen Pu, Xintao Wang, Yuchen Zhang, Ting Jiang, Yanjun Ge & Haiyan Zhu. (2022) A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer. Frontiers in Genetics 13.
Crossref
Soudeh Ghafouri-Fard, Arian Askari, Bashdar Mahmud Hussen, Mohammad Taheri & Majid Mokhtari. (2022) A long non-coding RNA with important roles in the carcinogenesis. Frontiers in Cell and Developmental Biology 10.
Crossref
Xin Chen, Yi Liu, Hejing Liu, Zhi-wei Wang & Xueqiong Zhu. (2022) Unraveling diverse roles of noncoding RNAs in various human papillomavirus negative cancers. Pharmacology & Therapeutics 238, pages 108188.
Crossref
Yi Liu, Hejing Liu, Bo Sheng, Shuya Pan, Zhi-wei Wang & Xueqiong Zhu. (2022) The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer. Apoptosis 27:9-10, pages 685-696.
Crossref
J. Tang, H. Pan, W. Wang, C. Qi, C. Gu, A. Shang & J. Zhu. (2021) MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer. Clinical and Translational Oncology 23:11, pages 2323-2334.
Crossref
Zhenghui Sui & Xin Sui. (2021) Long non‑coding RNA TMPO‑AS1 promotes cell proliferation, migration, invasion and epithelial‑to‑mesenchymal transition in gallbladder carcinoma by regulating the microRNA‑1179/E2F2 axis. Oncology Letters 22:6.
Crossref
Ting Luo, Yan Jiang & Jing Yang. (2021) Long Noncoding RNA LINC01554 as a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer. Disease Markers 2021, pages 1-5.
Crossref
Qiuxian ZhengJunjun JiaZiyuan ZhouQingfei ChuWenwen LianZhi Chen. (2021) The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers. DNA and Cell Biology 40:7, pages 848-857.
Crossref
Yajing Li. (2020) MIR31HG exhibits oncogenic property and acts as a sponge for miR-361-3p in cervical carcinoma. Biochemical and Biophysical Research Communications 529:4, pages 890-897.
Crossref